127 related articles for article (PubMed ID: 38842451)
1. The new definition of dominant stricture in primary sclerosing cholangitis: Prevalence and clinical significance.
Thylin M; Färkkilä M; Kautiainen H; Barner-Rasmussen N; Jokelainen K; Puustinen L; Boyd S; Arola J; Tenca A
Liver Int; 2024 Jun; ():. PubMed ID: 38842451
[TBL] [Abstract][Full Text] [Related]
2. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography.
Enns R; Eloubeidi MA; Mergener K; Jowell PS; Branch MS; Baillie J
Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468
[TBL] [Abstract][Full Text] [Related]
3. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis.
Thosani N; Banerjee S
Clin Liver Dis; 2014 Nov; 18(4):899-911. PubMed ID: 25438290
[TBL] [Abstract][Full Text] [Related]
5. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma].
Yuan J; Han GH
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847
[TBL] [Abstract][Full Text] [Related]
6. Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture.
Ahmad J
Hepatol Int; 2018 Nov; 12(6):510-519. PubMed ID: 30430358
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective.
Alkhatib AA; Hilden K; Adler DG
Dig Dis Sci; 2011 Dec; 56(12):3685-8. PubMed ID: 21789539
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic Management of Primary Sclerosing Cholangitis.
Barkin JA; Levy C; Souto EO
Ann Hepatol; 2017 November-December,; 16(6):842-850. PubMed ID: 29055922
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist.
Modha K; Navaneethan U
World J Hepatol; 2015 Apr; 7(5):799-805. PubMed ID: 25914780
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
11. Value of brush cytology for dominant strictures in primary sclerosing cholangitis.
Ponsioen CY; Vrouenraets SM; van Milligen de Wit AW; Sturm P; Tascilar M; Offerhaus GJ; Prins M; Huibregtse K; Tytgat GN
Endoscopy; 1999 May; 31(4):305-9. PubMed ID: 10376457
[TBL] [Abstract][Full Text] [Related]
12. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
[TBL] [Abstract][Full Text] [Related]
13. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Bowlus CL; Lim JK; Lindor KD
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2416-2422. PubMed ID: 31306801
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic management of primary sclerosing cholangitis.
Tabibian JH; Baron TH
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):693-703. PubMed ID: 29883229
[TBL] [Abstract][Full Text] [Related]
15. Probe-based confocal laser endomicroscopy in the evaluation of dominant strictures in patients with primary sclerosing cholangitis: results of a U.S. multicenter prospective trial.
Han S; Kahaleh M; Sharaiha RZ; Tarnasky PR; Kedia P; Slivka A; Chennat JS; Joshi V; Sejpal DV; Sethi A; Shah RJ
Gastrointest Endosc; 2021 Sep; 94(3):569-576.e1. PubMed ID: 33798541
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study.
Poetter-Lang S; Messner A; Bastati N; Ringe KI; Ronot M; Venkatesh SK; Ambros R; Kristic A; Korajac A; Dovjak G; Zalaudek M; Hodge JC; Schramm C; Halilbasic E; Trauner M; Ba-Ssalamah A
Eur Radiol; 2023 Dec; 33(12):9022-9037. PubMed ID: 37470827
[TBL] [Abstract][Full Text] [Related]
17. Three-months duration of fully-covered metal stent for refractory dominant extra-hepatic biliary stricture among primary sclerosing cholangitis patients: efficacy and safety.
Sbeit W; Khoury T; Goldin E; Mahamid M
Surg Endosc; 2022 Apr; 36(4):2412-2417. PubMed ID: 33977375
[TBL] [Abstract][Full Text] [Related]
18. Biliary endoscopy in the management of primary sclerosing cholangitis and its complications.
Fung BM; Tabibian JH
Liver Res; 2019 Jun; 3(2):106-117. PubMed ID: 31341699
[TBL] [Abstract][Full Text] [Related]
19. Cholangiographic findings in deteriorating primary sclerosing cholangitis.
Van Laethem JL; Devière J; Bourgeois N; Love J; Gelin M; Cremer M; Adler M
Endoscopy; 1995 Mar; 27(3):223-8. PubMed ID: 7664699
[TBL] [Abstract][Full Text] [Related]
20. Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis.
Rupp C; Hippchen T; Bruckner T; Klöters-Plachky P; Schaible A; Koschny R; Stiehl A; Gotthardt DN; Sauer P
Gut; 2019 Dec; 68(12):2170-2178. PubMed ID: 30910856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
